Showing 12,021 - 12,040 results of 65,955 for search '(( 5 wt decrease ) OR ( 5 ((we decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 0.68s Refine Results
  1. 12021
  2. 12022

    Data_Sheet_1_Long-term effects of the gait treatment using a wearable cyborg hybrid assistive limb in a patient with spinal and bulbar muscular atrophy: a case report with 5 years... by Kensuke Iijima (16076471)

    Published 2023
    “…Thus, this study aimed to investigate the long-term effects of the continued gait treatment with HAL in a patient with SBMA.</p>Results<p>A 68-year-old man with SBMA had lower limb muscle weakness and atrophy, gait asymmetry, and decreased walking endurance. …”
  3. 12023
  4. 12024
  5. 12025
  6. 12026
  7. 12027

    Transitioning of people with T1D from Multiple Daily Injections (MDI) and Self-Monitoring of Blood Glucose (BGM) directly to MiniMed™ 780G Advanced Hybrid Closed Loop (AHCL) system... by Bartłomiej Matejko (13180606)

    Published 2022
    “…</p> <p>Results: 41 participants were recruited and randomized to either the AHCL (20) or the MDI+BGM (21) group. 37 participants (age 40.3±8.0 years; duration of diabetes 17.3 ± 12.1 years; BMI 25.1±3.1 kg/m2; HbA1c 7.2% ± 1.0) completed the study. Time spent in target (TIR) increased from 69.3±12.3% at baseline to 85.0±6.3% at 3 months in the AHCL group, while remaining unchanged in the control group: treatment effect 21.5% [95% CI 15.7, 27.3%]; p < 0.001. …”
  8. 12028

    <b>Predictors of initial and sustained glycemic and weight response to tirzepatide: a post hoc analysis of SURPASS-4</b> by Ewan R. Pearson (157520)

    Published 2025
    “…For tirzepatide-treated participants achieving HbA1c ≤48 mmol/mol (6.5%) at 52 weeks, 75-84% sustained this until study end (median: 81 weeks). …”
  9. 12029
  10. 12030
  11. 12031
  12. 12032
  13. 12033
  14. 12034
  15. 12035
  16. 12036
  17. 12037
  18. 12038
  19. 12039
  20. 12040